In hepatocellular cancer, Aminopeptidase N is thought to regulate phosphorylation of Ser31 of BDK, which then increases BDK-mediated phosphorylation and activation of ERK1/2, a modification that is associated with increased hepatocellular carcinoma metastasis. Here, BCKDK is linked to hepatocellular carcinoma.